Literature DB >> 11641392

Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting.

A Marchese1, J L Benovic.   

Abstract

Ligand-induced trafficking plays an important role in the physiologic regulation of many G protein-coupled receptors (GPCRs). Although numerous GPCRs are sorted to a degradative pathway upon prolonged stimulation, the molecular events leading to degradation are poorly understood. Here we report that the human immunodeficiency virus co-receptor CXCR4 undergoes rapid agonist-promoted degradation by a process involving endocytosis via clathrin-coated pits and subsequent sorting to lysosomes. Studies analyzing the sorting of various CXCR4 mutants revealed the presence of a degradation motif (SSLKILSKGK) in the carboxyl terminus of CXCR4. The first two serines as well as the dileucine motif were critical for agonist-induced endocytosis, whereas all three serines but not the dileucine were important in mediating degradation. Mutation of the three lysine residues had no effect on CXCR4 endocytosis yet completely inhibited receptor degradation. Because lysine residues represent potential sites of ubiquitination, we also examined the ubiquitination of CXCR4. Interestingly, CXCR4 was shown to undergo rapid agonist-promoted ubiquitination that was attenuated by mutation of the lysine residues within the degradation motif. These studies implicate a specific role for ubiquitination in sorting endocytosed GPCRs to lysosomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641392     DOI: 10.1074/jbc.C100527200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  167 in total

1.  Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting toward lysosomes.

Authors:  Martin Sachse; Sylvie Urbé; Viola Oorschot; Ger J Strous; Judith Klumperman
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

Review 2.  Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 3.  Opioid receptor regulation.

Authors:  Mark von Zastrow
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 4.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

5.  The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.

Authors:  Kristina Subik; Lei Shu; Chengyu Wu; Qianqian Liang; David Hicks; Brendan Boyce; Linda Schiffhauer; Di Chen; Ceshi Chen; Ping Tang; Lianping Xing
Journal:  Bone       Date:  2012-01-11       Impact factor: 4.398

6.  Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling.

Authors:  Rohit Malik; Unice J K Soh; JoAnn Trejo; Adriano Marchese
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

7.  Ubiquitination in the first cytoplasmic loop of μ-opioid receptors reveals a hierarchical mechanism of lysosomal down-regulation.

Authors:  James N Hislop; Anastasia G Henry; Mark von Zastrow
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

Review 8.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

Review 9.  Ubiquitination of G protein-coupled receptors: functional implications and drug discovery.

Authors:  Michael R Dores; JoAnn Trejo
Journal:  Mol Pharmacol       Date:  2012-06-14       Impact factor: 4.436

Review 10.  G protein-coupled receptor sorting to endosomes and lysosomes.

Authors:  Adriano Marchese; May M Paing; Brenda R S Temple; JoAnn Trejo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.